Kirkland reviews the implications of ILPA's updated CV guidance on transaction processes, investor protections, and sponsor economics.
The sale comes almost four years after Ufenau transferred the equine veterinary group into a €563 million multi-asset CV.
The New York hire adds experience across secondary funds and GP-led liquidity transactions to the firm's Private Capital & Funds Practice.
Farrell brings experience across corporate and partnership tax matters, advising on GP-led secondaries, M&As, and other transactions.
SecondaryLink reviews the continuation fund activity of Q2 2026, covering asset composition, deal sizes, and the most active lead investors, advisors, and legal counsel.
Mayer Brown examines the evolving legal and governance framework for continuation vehicles as regulatory uncertainty, ILPA guidance, and litigation reshape GP-led transactions.
Osler examines key legal, regulatory, pricing, and conflict management considerations for sponsors and investors in GP-led transactions.
SecondaryLink reviews the continuation fund activity of Q1 2026, covering asset composition, deal sizes, and the most active lead investors, advisors, and legal counsel.
SecondaryLink reviews the continuation fund activity of Q4 2025, covering asset composition, deal sizes, and the most active lead investors, advisors, and legal counsel.
This Ropes & Gray podcast discusses how recent litigation around EMG's single-asset CV underscores complexities and conflicts inherent in GP-led transactions.
